Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.96 |
| ▸ | TSHR | P16473 | 3/20 | 0.96 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.96 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.96 |
| ▸ | KDR | P35968 | 1/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 4/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.77 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.77 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.77 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.69 |
| ▸ | CA12 | O43570 | 2/20 | 0.69 |
| ▸ | CA1 | P00915 | 2/20 | 0.69 |
| ▸ | CA2 | P00918 | 2/20 | 0.69 |
| ▸ | CA7 | P43166 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylparaben SCHEMBL2812583 | 1.00 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL977 | 0.98 | ESR1 (1.00) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL429594 | 0.98 | ESR1 (1.00) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL9406450 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL31538674 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL5671589 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL31530539 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL1135822 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL8779117 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 | |
| Propylparaben SCHEMBL6315856 | 0.96 | ESR1 (0.96) | ESR1ALDH1A1TSHRCHRM1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608929-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LyondellBasell Advanced Polymers Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12338390-B2 | Bridging particle and fluid loss control agent | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-06-24 | — | — | US | claimed |
| US-20240228859-A9 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024091462-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240132772-A1 | BRIDGING PARTICLE AND FLUID LOSS CONTROL AGENT | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2024-04-25 | — | — | US | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | claimed |
| US-7128923-B2 | Preserved and stable compositions containing peptide copper complexes and method related thereto | PROCYTE CORPORATION (US) | 2006-10-31 | — | — | US | claimed |
| EP-3592329-B1 | USE OF COMPATIBLE SOLUTES | SUSONITY Commercial GmbH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-12545860-B2 | Mannanase variants | BASF SE (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| WO-2004087740-A2 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | PROCYTE CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-6800671-B1 | UNSATURATED COMPOUND, ADHESION PROMOTER AND CURING AGENT; FLEXIBLE BIOADHESIVES | BRITESMILE, INC. | 2004-10-05 | — | — | US | disclosed |
| WO-2001081437-A1 | LOW PEAK EXOTHERM CURABLE COMPOSITIONS | BRITESMILE, INC. (US) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | ESR1 3004/4885ALDH1A1 4611/4885TSHR 1728/4885 |
| US-12545860-B2 | Mannanase variants | MAN2A1, MANBA, IDUA | ESR1 4832/4885ALDH1A1 4513/4885TSHR 3031/4885 |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | AOC1, NONO, CUTA | ESR1 978/4885ALDH1A1 340/4885TSHR 1460/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | ESR1 2772/4885ALDH1A1 1926/4885TSHR 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.